202 related articles for article (PubMed ID: 24591096)
1. Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys.
Pennypacker BL; Chen CM; Zheng H; Shih MS; Belfast M; Samadfam R; Duong LT
J Bone Miner Res; 2014 Aug; 29(8):1847-58. PubMed ID: 24591096
[TBL] [Abstract][Full Text] [Related]
2. Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey.
Cusick T; Chen CM; Pennypacker BL; Pickarski M; Kimmel DB; Scott BB; Duong LT
J Bone Miner Res; 2012 Mar; 27(3):524-37. PubMed ID: 22113921
[TBL] [Abstract][Full Text] [Related]
3. Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
Duong LT; Pickarski M; Cusick T; Chen CM; Zhuo Y; Scott K; Samadfam R; Smith SY; Pennypacker BL
Bone; 2016 Jul; 88():113-124. PubMed ID: 27126999
[TBL] [Abstract][Full Text] [Related]
4. Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys.
Masarachia PJ; Pennypacker BL; Pickarski M; Scott KR; Wesolowski GA; Smith SY; Samadfam R; Goetzmann JE; Scott BB; Kimmel DB; Duong LT
J Bone Miner Res; 2012 Mar; 27(3):509-23. PubMed ID: 22113859
[TBL] [Abstract][Full Text] [Related]
5. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.
Williams DS; McCracken PJ; Purcell M; Pickarski M; Mathers PD; Savitz AT; Szumiloski J; Jayakar RY; Somayajula S; Krause S; Brown K; Winkelmann CT; Scott BB; Cook L; Motzel SL; Hargreaves R; Evelhoch JL; Cabal A; Dardzinski BJ; Hangartner TN; Duong LT
Bone; 2013 Oct; 56(2):489-96. PubMed ID: 23806798
[TBL] [Abstract][Full Text] [Related]
6. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
7. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
8. Effects of Odanacatib on bone mineralization density distribution in thoracic spine and femora of ovariectomized adult rhesus monkeys: a quantitative backscattered electron imaging study.
Fratzl-Zelman N; Roschger P; Fisher JE; Duong LT; Klaushofer K
Calcif Tissue Int; 2013 Mar; 92(3):261-9. PubMed ID: 23179105
[TBL] [Abstract][Full Text] [Related]
9. Potential role of odanacatib in the treatment of osteoporosis.
Ng KW
Clin Interv Aging; 2012; 7():235-47. PubMed ID: 22866001
[TBL] [Abstract][Full Text] [Related]
10. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys.
Burr DB; Hirano T; Turner CH; Hotchkiss C; Brommage R; Hock JM
J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis.
Duong le T; Leung AT; Langdahl B
Calcif Tissue Int; 2016 Apr; 98(4):381-97. PubMed ID: 26335104
[TBL] [Abstract][Full Text] [Related]
12. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
[TBL] [Abstract][Full Text] [Related]
13. Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab.
Ominsky MS; Libanati C; Niu QT; Boyce RW; Kostenuik PJ; Wagman RB; Baron R; Dempster DW
J Bone Miner Res; 2015 Jul; 30(7):1280-9. PubMed ID: 25684625
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits.
Pennypacker BL; Duong LT; Cusick TE; Masarachia PJ; Gentile MA; Gauthier JY; Black WC; Scott BB; Samadfam R; Smith SY; Kimmel DB
J Bone Miner Res; 2011 Feb; 26(2):252-62. PubMed ID: 20734451
[TBL] [Abstract][Full Text] [Related]
15. Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate.
Muise ES; Podtelezhnikov AA; Pickarski M; Loboda A; Tan Y; Hu G; Thomspon JR; Duong le T
J Bone Miner Res; 2016 Apr; 31(4):839-51. PubMed ID: 26587671
[TBL] [Abstract][Full Text] [Related]
16. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
Vrahnas C; Buenzli PR; Pearson TA; Pennypacker BL; Tobin MJ; Bambery KR; Duong LT; Sims NA
Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
[TBL] [Abstract][Full Text] [Related]
17. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
[TBL] [Abstract][Full Text] [Related]
18. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
Khan MP; Singh AK; Singh AK; Shrivastava P; Tiwari MC; Nagar GK; Bora HK; Parameswaran V; Sanyal S; Bellare JR; Chattopadhyay N
J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
[TBL] [Abstract][Full Text] [Related]
19. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
Jerome C; Missbach M; Gamse R
Osteoporos Int; 2012 Jan; 23(1):339-49. PubMed ID: 21380636
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: a study with odanacatib treatment in the ovariectomized adult rhesus monkey.
Jayakar RY; Cabal A; Szumiloski J; Sardesai S; Phillips EA; Laib A; Scott BB; Pickarski M; Duong LT; Winkelmann CT; McCracken PJ; Hargreaves R; Hangartner TN; Williams DS
Bone; 2012 Jun; 50(6):1379-88. PubMed ID: 22469953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
